StonvexLoading…
StonvexCore line items from REFR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $136.32K | $1.12M | $1.05M | $689.68K |
Operating Income | $-530.41K | $-2.13M | $-1.36M | $-1.05M |
Net Income | $-525.37K | $-2.05M | $-1.28M | $-981.51K |
EPS (Diluted) | $-0.02 | $-0.06 | $-0.04 | $-0.03 |
Total Assets | $3.08M | $2.25M | $2.77M | $3.17M |
Total Liabilities | $1.30M | $1.32M | $1.27M | $1.37M |
Cash & Equivalents | $1.28M | $664.30K | $1.13M | $1.27M |
Free Cash Flow OCF − CapEx | $-760.00K | $-1.33M | $-863.80K | $-719.91K |
Shares Outstanding | 34.87M | 33.65M | 33.65M | 33.65M |